DOCTORS HOSPITAL OF RIVERSIDE
1. Target Overview & Investment Thesis
DOCTORS HOSPITAL OF RIVERSIDE is a 193-bed suburban community hospital in RIVERSIDE, CA with $139.0M in net patient revenue and a 4.4% operating margin. The hospital serves a payer mix of 20.9% Medicare, 10.2% Medicaid, and 68.9% commercial.
Thesis: Undervalued. Our ML models identify $10.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.4% to 11.8% (+736bps).
| Net Revenue HCRIS | $139.0M |
| Current EBITDA COMPUTED | $6.1M |
| Operating Margin COMPUTED | 4.4% |
| Occupancy HCRIS | 37.7% |
| Revenue / Bed COMPUTED | $720K |
| Net-to-Gross HCRIS | 18.2% |
| Distress Probability ML | 51.9% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 4.4% places it above the state median. Among 219 size-comparable peers (96-386 beds), the median margin is -4.6%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (96-386), prioritizing same-state peers. 219 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| DOCTORS HOSPITAL OF RIVERSIDE (Target) | CA | 193 | $139.0M | 4.4% |
| CITY OF HOPE NATIONAL MEDICAL | CA | 217 | $1.83B | -10.7% |
| HARBOR-UCLA MEDICAL CENTER | CA | 369 | $1.54B | -6.4% |
| CHILDRENS HOSPITAL OF ORANGE C | CA | 334 | $1.31B | 0.7% |
| KFH - SANTA CLARA | CA | 343 | $1.25B | 12.5% |
| KFH - ROSEVILLE | CA | 352 | $1.18B | 14.2% |
| KFH - OAKLAND | CA | 365 | $1.13B | -6.3% |
| KECK HOSPITAL OF USC | CA | 301 | $1.11B | -20.8% |
| SUTTER ROSEVILLE MEDICAL CENTE | CA | 318 | $1.07B | 12.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.9M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.8M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.7M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $89K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $6.1M |
| + RCM Uplift | +$10.2M |
| Pro Forma EBITDA | $16.3M |
| Current Margin | 4.4% |
| Pro Forma Margin | 11.8% |
| WC Released (1x) | $5.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $9.4M | $142.6M | 15.17x | 72.3% |
| Base (11x exit) | 10.0x | 11.0x | $9.4M | $159.9M | 17.01x | 76.2% |
| Bull Case | 9.0x | 11.0x | $8.5M | $196.7M | 23.25x | 87.6% |
| Bull (12x exit) | 9.0x | 12.0x | $8.5M | $217.1M | 25.66x | 91.4% |
| Bear Case | 11.0x | 10.0x | $10.3M | $88.4M | 8.55x | 53.6% |
| Bear (11x exit) | 11.0x | 11.0x | $10.3M | $100.6M | 9.73x | 57.6% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Elevated distress probability | Model estimates 51.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 219 hospitals with 96-386 beds
- Same-state prioritization (n=220)
- Comp margins: P25=-17.2% / P50=-4.6% / P75=4.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.